Could a Norwegian pill be part of the solution to the Covid crisis?
The Norwegian biotech company BerGenBio is testing it’s cancer medicine Bemcentinib against Covid infections in the UK ACCORD trial, as well as it’s self funded trials in South Africa and India. First data is expected early this year.
From the ACCORD website at https://www.accord-trial.org
“Bemcentinib – AXL inhibitor with early data showing it can reduce viral infection and lung inflammation and blocks the SARS-CoV-2 coating from interacting and gaining entry into cells”
Also see page 38 to 41 in this PDF presentation from BerGenBio: https://www.bergenbio.com/wp-content/uploads/2021/01/BerGenBio_SEB_Jan21.pdf and their pipepline at their home page https://www.bergenbio.com/pipeline/bemcentinib-covid-19/
And also see one of the latest video sessions with the CEO at https://dnb-play.screen9.tv/media/E0TATxo3cmugURN4iOD2vA/dnb-markets-session-i-bergenbio and the analyst report https://www.edisongroup.com/publication/bemcentinib-leading-the-axl-charge/28247/ and their update to the report at https://edisongroup.com/publication/progressing-towards-key-inflection-points/28511
Maybe Dr. Chris Martenson could take a closer look at Bemcentinib in one of his videos as a potential treatment for Covid, especially in these times with so many mutations and uncertainty about the vaccines.
BerGenBio is listed at the Oslo Stock Exchange under ticker “BGBIO”: https://live.euronext.com/en
Another injectable-only, expensive biologic… this one an inhibitor of AXL kinase, or of “intracellular catalytic kinase domain of AXL receptor tyrosine kinase”. I see no reason why this should be useful at all, particularly compared to the other biologics that target more useful mechanisms.
This is actually from April 2020, so this has been under testing for quite some time. This is a Norwegian company so they’re not likely to get emergency approval like the genocidal Big Pharma companies, even if it were as effective as or more effective than meplazumab (a humanized anti-CD147 antibody), leronlimab (targets the chemokine receptor CCR5), STI-1499 (unspecified “100% inhibition” antibody magic), REGN-COV2 (two monoclonal antibodies that bind non-competitively to different sites of the receptor binding domain of the Spike protein), bamlanivimab/etesevimab (same but from lab-full-of-feces-fans Eli Lilly), or anakinra (a “modified version of the human interleukin 1 receptor antagonist protein”), i.e. the non-vaccine biologics produced by larger pharma companies.
edit: OK, I see why it’s supposed to be useful. Their site says: “Bemcentinib is a small molecule inhibitor that targets a cell-surface protein called AXL, which is one of several cell surface receptors used by enveloped viruses to enter cells” – Alright, I hadn’t seen that AXL has been proposed as a SARS-CoV-2 target.
Then it says: “Bemcentinib prevents inhibition of Type I Interferon, which is the cell’s anti-viral defence mechanism, again suggesting valuable utility in treatment of SARS-CoV-2 infection” – Yet the WHO and the fraud-filled “medical” system continue maintaining that interferon is not useful.
So yeah, it’s another biologic that is potentially useful but far less accessible than vitamin D, quercetin (which increases interferon), echinacea, and the many other immune-building supplements and cheap and effective treatments.
It’s not at all “abandoned”. The Bemcentinib Covid trials is ongoing, both in ACCORD in UK and South Africa and India.
Regarding the trials in South Africa and India, the iDMC committee just now 11 of january 2021 recommends continuation of BerGenBio’s BGBC020 trial accessing Bemcentinib in Covid 19 patients, please read about it here: https://newsweb.oslobors.no/message/522323
Regarding the ACCORD trial in UK please see this message from 8 of December 2020: https://newsweb.oslobors.no/message/519960 – where they confirms first Covid-19 patient enrolled with Bemcentinib in ACCORD trial.
Yeah, I corrected that, sorry. It started April 2020 and has yet to be approved, while the Big Pharma companies get their biologics approved rapidly.
Looks useful actually, if indeed AXL is a bigger target than ACE2 in the lungs. Of course vitamin D, zinc, vitamin C, chlorine dioxide, niacin, and/or ivermectin, HCQ, etc are more than enough to end the plandemic. We don’t really need any more exotic injectable-only stuff. Though I’d trust a Norwegian pharma company much before I’d trust Pfizer (which has an extremely long criminal history), Moderna (a cancer company), or anyone connected to Oxford or the genocidal British or American establishment, etc.
Maybe I misunderstand you regarding “injectable-only stuff”, but please note that Bemcentinib is a pill/tablets, not something that you would inject like the vaccines.
You might find this article interesting (published 8 of january this year): “AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells”: https://www.nature.com/articles/s41422-020-00460-y
Well I already learned how to spell, Tocilizumab.
Getting ready for the Covid19 Spelling Bee.
Bem cent in ib
Ah, right, so it’s not actually a biologic, it’s a drug, thus potentially accessible outside of hospital settings. Not what you expect with a suffix like -inib. The difference between a small pharma company and a Big Pharma one, I guess.
That’s the same article as I referred to in my first post, just from a different site. Interesting that they’re now saying AXL is more relevant than ACE2, after the election theft. And that it’s called “tyrosine-protein kinase receptor UFO (AXL)” seems like a premonition of things to come!
Great find, long41.
Here is a promising paper published 28 January 2021 regarding bemcentinib from BerGenBio and covid-19:
Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology: https://www.biorxiv.org/content/10.1101/2020.05.28.122291v2.full
No time to test exotic meds. Even if it’s aleady approved for cancer, few people have used it. Devil is in the details and many side effects can become troublesome if millions of people were to use it.
Best to stick to widely known repurposed meds.